Time on boards
- Boards served
- 4
- Current seats
- 4
- Board service
- 14 years
- Director since
- 2023
14 years of board service in total across 4 boards, counting each seat separately. Longest: ACADIA Pharmaceuticals Inc., 3 years.
ACADIA Pharmaceuticals Inc.
Director
Pacira BioSciences Inc.
Director
Edgewise Therapeutics Inc.
Director
Mirum Pharmaceuticals Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 16, 2024 | Pacira BioSciences Inc. | Open-market purchase | +1,000 | $12.81 | $12,810 |
| Jun 12, 2024 | Pacira BioSciences Inc. | Grant or award | +5,230 | — | — |
| May 29, 2024 | ACADIA Pharmaceuticals Inc. | Option exercise | +6,652 | — | — |
| Jun 14, 2023 | Pacira BioSciences Inc. | Grant or award | +1,775 | — | — |
| Jun 12, 2023 | ACADIA Pharmaceuticals Inc. | Open-market sale | −4,500 | $24.87 | $111,915 |
| Jun 5, 2023 | Pacira BioSciences Inc. | Open-market sale | −600 | $38.74 | $23,244 |
| Jun 1, 2023 | ACADIA Pharmaceuticals Inc. | Option exercise | +8,552 | — | — |
| Apr 3, 2023 | Pacira BioSciences Inc. | Option exercise | +7,000 | $29.90 | $209,300 |
| Apr 3, 2023 | Pacira BioSciences Inc. | Open-market sale | −7,000 | $40.72 | $285,040 |
| Jan 12, 2023 | ACADIA Pharmaceuticals Inc. | Option exercise | +12,500 | $17.01 | $212,625 |
| Jan 12, 2023 | ACADIA Pharmaceuticals Inc. | Open-market sale | −12,500 | $18.25 | $228,125 |
| Jun 7, 2022 | ACADIA Pharmaceuticals Inc. | Option exercise | +6,391 | — | — |
| Jun 22, 2021 | ACADIA Pharmaceuticals Inc. | Option exercise | +3,059 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.